Latest Revenue Forecast News

Cavalier Resources appoints Colin Bald as General Manager Operations and releases an updated Pre-Feasibility Study for its Crawford Gold Project, highlighting robust financial metrics and a clear path to production.

Electro Optic Systems projects first-half 2025 revenue between A$40 million and A$45 million, underpinned by a major Middle East contract and a growing contract backlog now at A$170 million.

Veris Limited has announced a significant turnaround in FY25 with an expected profit before tax of up to $2 million, reversing last year's loss, driven by strategic digital spatial initiatives and acquisition integration.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

SHAPE Australia reports a robust FY25 with revenue nearing $960 million and a historic project pipeline of $4 billion, signaling strong growth ahead.

Australian Silica Quartz Group's flagship Quartz Hill MGSi Project faces a setback after Quinbrook Infrastructure Partners terminates their development and offtake agreement. ASQ pivots to explore other high-grade quartz targets in Queensland.

Bioxyne Limited has upgraded its FY2025 revenue guidance to approximately $28 million, driven by strong domestic performance and significant progress in European and UK markets. The company also advances its psychedelic medicines pipeline, positioning itself for sustained growth.

Motio Limited has upgraded its FY25 revenue and EBITDA guidance following unexpectedly strong trading conditions after the Federal Election, driven by a surge in national and programmatic advertising.

Aurizon has landed a major 15-year contract to manage BHP’s Copper South Australia logistics, investing $100 million in new infrastructure and promising a greener, safer transport solution.

Adisyn Ltd has successfully completed a key R&D program on low-temperature graphene deposition, earning full approval and final payment of a $520,000 grant from the Israel Innovation Authority. This milestone validates its cutting-edge semiconductor technology aimed at revolutionizing AI and high-performance computing.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.